Expression of biomarkers (p53, transforming growth factor alpha, epidermalgrowth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas

Citation
So. Ibrahim et al., Expression of biomarkers (p53, transforming growth factor alpha, epidermalgrowth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas, ORAL ONCOL, 35(3), 1999, pp. 302-313
Citations number
50
Categorie Soggetti
Oncology
Journal title
ORAL ONCOLOGY
ISSN journal
13688375 → ACNP
Volume
35
Issue
3
Year of publication
1999
Pages
302 - 313
Database
ISI
SICI code
1368-8375(199905)35:3<302:EOB
Abstract
Using immunohistochemistry, expression of p53, transforming growth factor-a lpha (TGF-alpha), epidermal growth factor receptor (EGFR), c-erbB-2/neu and proliferating cell nuclear antigen (PCNA) was examined in 26 fresh frozen tissue specimens of oropharyngeal squamous cell carcinomas (SCCs). p53 gene mutations were examined by polymerase chain reaction (PCR)/DNA sequencing methods in 22 carcinomas. The findings were examined for correlations with patients' clinicopathological parameters. Expressions of p53 and PCNA were also examined in 21 formalin-fixed corresponding tissues. Of the fresh froz en tissue specimens, 77% (20/26) showed expression and 68% (15/22) showed m utations (substitutions) of the p53, with significant clustering of the mut ations in exons 5 (8/22; 36%), 7 (4/22; 18%) and 8 (5/22; 23%). No mutation s were found in exon 6. There was a discordance between expression of p53 p rotein and mutations of the gene. Parallel to expression and mutations of t he p53 found in most of the specimens, expression of TGF-alpha, EGFR, c-erb B-2/neu and PCNA was found in 88% (22/25), 92% (23/25), 58% (14/24) and 91% (21/23) of the specimens, respectively. For the formalin-fixed tissue spec imens, 62% (13/21) and 90% (19/21) expressed p53 and PCNA, respectively. Ex amining for correlations with patients' clinicopathological parameters, exp ression of p53, TGF-alpha, EGFR and c-erbB-2/neu seemed to negatively corre late with the increase of the tumour grade. The present work suggests that: (1) lack of negative growth regulation due to inactivation of the p53 gene together with activation of other proto-oncogenes are necessary genetic ev ents in the carcinogenesis of oropharyngeal SCCs; (2) in oropharyngeal SCCs , p53 gene mutations were clustered in exons 5 (codons 130-186), 7 (codons 230-248) and 8 (codons 271-282) which perhaps suggests that tobacco carcino gens probably affect the mutational hot spots of the p53 gene at codons 157 , 175, 186, 248, 273 and 282; and (3) fresh frozen and formalin-fixed tissu e specimens give similar results when an immunohistochemical method is appl ied. The importance of p53, TGF-alpha, EGFR, c-erbB-2/neu and PCNA as bioma rkers in oropharyngeal SCCs deserves particular attention because it might offer further understanding of the development of these carcinomas. (C) 199 9 Elsevier Science Ltd. All rights reserved.